Abstract
So far, case–control studies on the association between glucose transporter 1 (GLUT1) gene single nucleotide polymorphisms (SNPs) and diabetic nephropathy (DN) have generated considerable controversy. To clarify the linkage of GLUT1 SNPs on the risk of DN, a systematic review and meta-analysis was performed. A comprehensive literature search of electronic databases was conducted to obtain relative studies. Nine case–control studies were included. Significant differences were found between XbaI SNP (rs841853) and increased risk of DN in all genetic models. Subgroup analyses for Caucasians population and DN from both type 1 and type 2 diabetes also revealed positive results. For Enh2-1 SNP (rs841847), Enh2-2 SNP (rs841848) and HaeIII SNP (rs1385129), obvious linkages were demonstrated in recessive model. However, analysis for the association between HpyCH4V SNP (rs710218) and the susceptibility of DN showed no significance. Likewise, negative outcome was also found in the assessment for the influence of XbaI or Enh2-2 SNP on the pathogenesis progress of DN. The evidence currently available shows that XbaI, Enh2 and HaeIII SNPs, but not HpyCH4V SNP, in GLUT1 gene may be genetic susceptibility to DN. However, data does not support the association between either XbaI or Enh2-2 SNP and the severity of DN.
Similar content being viewed by others
References
Gross JL, de Azevedo MJ, Silveiro SP et al (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28:164–176
Zhang P, Zhang X, Brown J et al (2010) Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:293–301
De Cosmo S, Prudente S, Lamacchia O et al (2011) PPARγ2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies. Nephrol Dial Transplant 26:4011–4016
He Y, Fan Z, Zhang J et al (2011) Polymorphisms of eNOS gene are associated with diabetic nephropathy: a meta-analysis. Mutagenesis 26:339–349
Cui WP, Du B, Jia Y et al (2012) Is C677T polymorphism in methylenetetrahydrofolate reductase gene a risk factor for diabetic nephropathy or diabetes mellitus in Chinese population? Arch Med Res 43:42–50
Manolescu AR, Witkowska K, Kinnaird A et al (2007) Facilitated hexose transporters: new perspectives on form and function. Physiology (Bethesda) 22:234–240
Baldwin SA, Lienhard GE (1989) Purification and reconstitution of glucose transporter from human erythrocytes. Methods Enzymol 174:39–50
Heilig C, Zaloga C, Lee M et al (1995) Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney. Lab Invest 73:674–684
Heilig CW, Liu Y, England RL et al (1997) d-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications of diabetic nephropathy. Diabetes 46:1030–1039
Brosius FC, Heilg CW (2005) Glucose transporters in diabetic nephropathy. Pediatr Nephrol 20:447–451
Ziyadeh FN (2004) Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol 15:55–57
Wang Y, Heilig KO, Minto AW et al (2010) Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF. Lab Invest 90:83–97
Studer RK, Craven PA, DeRubertis FR (1993) Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes 42:118–126
Pfäfflin A, Brodbeck K, Heilig CW et al (2006) Increased glucose uptake and metabolism in mesangial cells overexpressing glucose transporter 1 increases interleukin-6 and vascular endothelial growth factor production: role of AP-1 and HIF-1alpha. Cell Physiol Biochem 18:199–210
Heilig CW, Kreisberg JI, Freytag S et al (2001) Antisense GLUT1 protects mesangial cells from glucose induction of GLUT1 and fibronectin. Am J Physiol Renal Physiol 280:F657–F666
Hsu CC, Kao WL, Steffes MW et al (2011) Genetic variation of glucose transporter-1 (GLUT1) and albuminuria in 10,278 European Americans and African Americans: a case-control study in the Atherosclerosis risk in Communities (ARIC) study. BMC Med Genet 12:16–28
Stefanidis I, Kytoudis K, Papathanasiou AA et al (2009) XbaI GLUT1 gene polymorphism and the risk of type 2 diabetes with nephropathy. Dis Markers 27:29–35
Makni K, Jarraya F, Rebaï M et al (2008) Risk genotypes and haplotypes of the GLUT1 gene for type 2 diabetic nephropathy in the Tunisian population. Ann Hum Biol 35:490–498
Hodgkinson AD, Page T, Millward BA et al (2005) A novel polymorphism in the 5′ flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus. J Diabetes Complicat 19:65–69
Ng DP, Canani L, Araki S et al (2002) Minor effect of GLUT1 polymorphisms on susceptibility to diabetic nephropathy in type 1 diabetes. Diabetes 51:2264–2269
Hodgkinson AD, Millward BA, Demaine AG (2001) Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy. Kidney Int 59:985–989
Tarnow L, Grarup N, Hansen T et al (2001) Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients. Nephrol Dial Transplant 16:1653–1656
Liu ZH, Guan TJ, Chen ZH et al (1999) Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus. Kidney Int 55:1843–1848
Gutierrez C, Vendrell J, Pastor R et al (1998) GLUT1 gene polymorphism in non-insulin-dependent diabetes mellitus: genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population. Diabetes Res Clin Pract 41:113–120
Grzeszczak W, Moczulski DK, Zychma M et al (2001) Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes. Kidney Int 59:631–636
Lau J, Ioannidis JP, Schmid CH (1998) Summing up evidence: one answer is not always enough. Lancet 351:570–573
Lau J, Ioannidis JP, Schmid CH (1997) Qauntitative synthesis in systematic reviews. Ann Intern Med 127:820–826
Zintzaras E, Ioannidis JP (2005) HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 21:3672–3673
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
Harel Z, Gilbert C, Wald R, et al. (2012) The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis. BMJ [Epub ahead of print]
Leucht S, Corves C, Arbter D et al (2009) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373:31–41
Wang Y, Chen J, Wang Y et al (2011) A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy. Nephrol Dial Transplant 26:1923–1931
Mueckler M, Caruso C, Baldwin SA et al (1985) Sequence and structure of a human glucose transporter. Science 229:941–945
Hruz PW, Mueckler MM (2001) Structural analysis of the GLUT1 facilitative glucose transporter (review). Mol Membr Biol 18:183–193
Arnoni CP, Lima C, Cristovam PC et al (2009) Regulation of glucose uptake in mesangial cells stimulated by high glucose: role of angiotensin II and insulin. Exp Biol Med (Maywood) 234:1095–1101
Sokolovska J, Isajevs S, Sugoka O et al (2010) Influence of metformin on GLUT1 gene and protein expression in rat streptozotocin diabetes mellitus model. Arch Physiol Biochem 116:137–145
Heilig CW, Concepcion LA, Riser BL et al (1995) Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96:1802–1814
Wang Y, Heilig K, Saunders T et al (2010) Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis. Am J Physiol Renal Physiol 299:99–111
Tao T, Tanizawa Y, Matsutani A et al (1995) HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects. Diabetologia 38:942–947
Baroni MG, D’Andrea MP, Capici F et al (1998) High frequency of polymorphism but no mutations found in the GLUT1 glucose transporter gene in NIDDM and familial obesity by SSCP analysis. Hum Genet 102:479–482
Lefrançois-Martinez AM, Martinez A, Antoine B et al (1995) Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J Biol Chem 270:2640–2643
Gosek K, Moczulski D, Zukowska-Szczechowska E et al (2005) C-106T polymorphism in promoter of aldose reductase gene is a risk factor for diabetic nephropathy in type 2 diabetes patients with poor glycemic control. Nephron Exp Nephrol 99:63–67
Sivenius K, Niskanen L, Voutilainen-Kaunisto R et al (2004) Aldose reductase gene polymorphisms and susceptibility to microvascular complications in Type 2 diabetes. Diabet Med 21:1325–1533
Zhao HL, Tong PC, Lai FM et al (2004) Association of glomerulopathy with the 5′-end polymorphism of the aldose reductase gene and renal insufficiency in type 2 diabetic patients. Diabetes 53:2984–2991
Costa GC, Alcantara LC, Azevedo R et al (2010) Frequency distribution of XbaIG > T and HaeIII T > C GLUT1 polymorphisms among different Brazilian ethnic groups. Mol Biol Rep 37:75–79
Li SR, Oelbaum RS, Bouloux PM et al (1990) Restriction site polymorphisms at the human HepG2 glucose transporter gene locus in Caucasian and west Indian subjects with non-insulin-dependent diabetes mellitus. Hum Hered 40:38–44
Zintzaras E, Stefanidis I (2005) Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis. J Hum Genet 50:84–91
Mooyaart AL, Valk EJ, van Es LA et al (2011) Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia 54:544–553
Acknowledgments
We would like to express our gratitude to all the physicians participating in this work.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Wenpeng Cui and Bing Du contributed equally to this work and should be considered co-first authors.
Rights and permissions
About this article
Cite this article
Cui, W., Du, B., Zhou, W. et al. Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysis. Mol Biol Rep 39, 8551–8558 (2012). https://doi.org/10.1007/s11033-012-1711-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-012-1711-z